Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.
Last trade$31.64
Day change-$0.07 (-0.22%)
Day range$31.50 – $31.80
Volume2,227,736
Market cap$4.75B
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$4.75B
Price / earnings
22.07×
Price / book
3.59×
Price / sales
0.83×
EV / sales
0.98×
EV / EBITDA
13.63×
Profitability
Earnings per share
$1.44
Return on assets
6.19%
Return on equity
16.25%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0.87×
Current ratio
1.54×
Quick ratio
1.06×
Cash ratio
0.35×
Cash flow
Price / cash flow
14.75×
Price / free cash flow
16.87×
Free cash flow
$281.65M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for OPCH, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$1.49B
$1.44B
$1.35B
$1.47B
$1.44B
$1.42B
$1.33B
$1.35B
Cost of revenue
$1.21B
$1.18B
$1.09B
$1.18B
$1.16B
$1.15B
$1.07B
$1.08B
Gross profit
$284.97M
$267.25M
$262.01M
$282.9M
$272.9M
$269.04M
$263.05M
$268.38M
Selling, general and administrative
$177.64M
$164.66M
$174.56M
$172.14M
$172.1M
$170.09M
$168.12M
$164.73M
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$195.76M
$182.11M
$189.47M
$191.4M
$188.4M
$186.33M
$183.86M
$181.34M
Operating income
$89.22M
$85.14M
$72.55M
$91.5M
$84.51M
$82.71M
$79.19M
$87.04M
Interest expense
-$12.88M
-$14.02M
-$13.3M
-$12.73M
-$14.15M
-$14.45M
-$13.23M
-$10.88M
Income before taxes
$78.9M
$73.99M
$61M
$81.52M
$68.97M
$68.86M
$63.56M
$81.05M
Income taxes
$21.47M
$20.07M
$15.66M
$23.01M
$17.15M
$18.34M
$16.81M
$20.92M
Net income
$57.43M
$53.91M
$45.34M
$58.5M
$51.82M
$50.52M
$46.74M
$60.13M
Net income attributable to common shareholders
$57.43M
$53.91M
$45.34M
$58.5M
$51.82M
$50.52M
$46.74M
$60.13M
EBITDA
$108.05M
$103.52M
$88.2M
$111.82M
$101.56M
$99.66M
$95.56M
$104.51M
Basic earnings per share
$0.38
$0.35
$0.29
$0.37
$0.32
$0.31
$0.28
$0.36
Diluted earnings per share
$0.38
$0.35
$0.29
$0.37
$0.32
$0.31
$0.28
$0.35
Recent news
Company coverage with links to the original publishers.
BrightSpring Health Services (BTSG) shares jumped 11.3% following strong Q3 results with revenues up 26.4% to $4.21B and adjusted EPS surging 80%. The company raised its 2026 guidance, but its elevated 30.9X forward P/E valuation leaves limited room for execution errors. While specialty pharmacy growth and margin expansion support the rally, sustained earnings delivery and successful margin conversion remain critical for future gains.
Addus HomeCare reported Q3 2026 earnings of $1.83 per share, beating consensus estimates of $1.78, but revenues of $387.73 million slightly missed expectations. The company has outperformed the market by 17.1% year-to-date. With a Zacks Rank #3 (Hold) rating and mixed estimate revisions, the stock is expected to perform in line with the market. The Medical - Outpatient and Home Healthcare industry ranks in the top 39% of Zacks industries.
Option Care Health (OPCH) surged 32.7% following the announcement of its acquisition by CD&R and McKesson for $32.05 per share in cash, representing a 37% premium to the previous closing price. The $5.8 billion enterprise value deal underscores the strategic appeal of OPCH's home and alternate-site infusion care platform. However, with unchanged earnings estimate revisions over the past 30 days, analysts caution that sustained momentum may depend on future estimate trends.
Several stocks surged following major announcements: AMD rose 2.8% on plans to boost chip production in 2027 for AI demand. Constellation Energy jumped 12.3% after Google signed a $4.3 billion nuclear power deal. Option Care Health soared 32.7% on acquisition news from McKesson and Clayton, Dubilier & Rice. Vistra Corp. gained 10.8% after the Department of Energy committed $4.2 billion for nuclear facility upgrades.
Halper Sadeh LLC, an investor rights law firm, is investigating PTC Inc. and Option Care Health, Inc. for potential violations of federal securities laws and breaches of fiduciary duties relating to their proposed acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits or terms limiting competing offers are present in these transactions.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.